Xile HuXile Hu was born in 1978 in Putian, southeastern China. He entered the Peking University in Beijing in 1996. Besides learning too little chemistry, his biggest regret in the college was not able to correct his southern accent in Mandarin. After graduated from PKU, he went to the United States and began his doctoral studies at the University of California, San Diego. In December 2004, he finished with a Ph.D. in chemistry and some fond memories of the beautiful city of San Diego. He then moved to the Los Angeles area and become a postdoctoral scholar at the California Institute of Technology. There he enjoyed numerous stimulating scientific (and other) discussions with friends and colleagues. He also made plenty of friends outside the campus and was a frequent in many local Chinese restaurants. In 2007, after two pleasant visits to Switzerland, he decided to move across the continent one more time and join the faculty of the École Polytechnique Fédérale de Lausanne (EPFL). He now directs the Laboratory of Inorganic Synthesis and Catalysis and is interested in developing chemistry for synthesis, energy and sustainability.
Christian Gabriel TheilerChristian Theiler obtained his Master’s degree in physics from ETH Zurich in 2007 and his PhD from EPFL in 2011. He then joined MIT as a postdoctoral associate to work on the Alcator C-Mod tokamak. In 2014, he returned to EPFL as a EUROfusion fellow, to join the TCV tokamak team. Two years later, he was named Tenure Track Assistant Professor in Plasma Physics at EPFL. Christian’s research focuses on tokamak boundary physics and related diagnostic techniques. He has contributed to the understanding of the formation, propagation, and control of turbulent plasma structures, called blobs, and gained new insights on the structure of transport barriers in the plasma periphery in different high-confinement regimes. His current research focuses on detachment physics and turbulence characteristics in conventional and alternative divertor magnetic geometries.
Florian Maria WurmFlorian Wurm received his academic training as a Biologist and Molecular Geneticist at the University of Giessen. He joined the Hoechst AG (Behringwerke) in Marburg as head of a laboratory in Virology. Working with immortalized mammalian cells for the establishment of production processes for alpha-interferons provided the first opportunity to combine basic research with medical application. In 1984 he joined Harvard Medical School in Boston as a Research Fellow in Molecular Biology. 1986 he took an offer from Genentech Inc. in San Francisco to work in Process Sciences on the development of large scale manufacturing processes for recombinant proteins. There he has held a number of leading positions and has acquired intimate knowledge in the generation of protein pharmaceuticals in mammalian cells in bioreactors (a number of which are now marketed products). In 1995 he joined the EPFL as a Professor for Biotechnology. Wurm has published more than 250 scientific papers and holds more than 20 patents/patent-applications. His H-index stands at 60 in 2021. He was Chairman (2005-2009) and is member of the Executive Board of the European Society of Animal Cell Technology (ESACT). He serves as a consultant to the pharmaceutical Biotech Industry, mainly in the fields of animal cell technology for recombinant protein production and in regulatory affairs. He works as a scientific reviewer and editior/asscciate editor for a number of international journals in the Biotech field. F.M. Wurm teaches classes to pre- and postgraduate students in the fields of Molecular and Cellular Biotechnology.
He was founder and Chief Scientific Officer of ExcellGene SA, a 2001 established company in Monthey, Switzerland. He took the position of President and CEO of ExcellGene in 2015. He retired from the CEO position in 2017 and continues to be President and Chief Scientific Officer of ExcellGene.
In 2008 Dr. Wurm was appointed Visiting Professor for Biotechnology at Jinan University in Guangzhou, China. He retired from his position at the EPFL in 2015. His laboratory is closed. With his team at ExcellGene and in collaboration with Dr. Paco Pino, Director of R&D, he continues to explore manufacturing sciences with animal cells in bioreactors.
Zhaofu Fei1999, Phd in Chemistry, Braunschweig, Germany,
2002, Lausanne, EPFL, Scientist.
Rakesh ChawlaOriginaire d'Inde, Rakesh Chawla y est né en 1947. Après avoir obtenu son doctorat en génie nucléaire à l'Imperial College de l'Université de Londres en 1970, il travaille jusqu'en 1972 à Winfrith comme Research Fellow de la United Kingdom Atomic Energy Authority.
De 1972 à 1978, il est engagé comme professeur assistant par l'Institut Indien de Technologie à Kanpur dans le cadre du programme Génie Nucléaire et Technologie. Depuis 1978, il travaille à l'Institut Paul Scherrer (PSI) à Würenlingen-Villigen dans le département de recherche Energie Nucléaire. En tant que chef de projet, il est responsable des divers travaux R&D, comme les études faites sur le réacteur de recherche PROTEUS.
En 1994, il est nommé professeur extraordinaire en physique des réacteurs au Département de physique de l'EPFL, poste qui comprend les activités d'enseignement à l'EPFL et la direction du Laboratoire de physique des réacteurs et de technique des systèmes au PSI. En 1997, il est nommé professeur ordinaire son enseignement porte sur les aspects physiques du génie nucléaire et les travaux pratiques utilisant le réacteur CROCUS à l'EPFL. Ses recherches actuelles comprennent les travaux expérimentaux et analytiques liés à la sécurité des systèmes avancés, au cycle de combustible et à la transmutation des déchets, ainsi qu'au comportement dynamique des centrales nucléaires.
